Testing Kits & Reagents for use with Government-Owned Analyzers; use of VITEK MS Prime Analyzer, including Service Agreements

The Medical Readiness Contracting Office – Pacific, in support of Tripler Army Medical Center (TAMC), Hawaii, intends to make a sole source award to BioMerieux, Inc. for the purchase of various blood culture monitoring and antibiotic susceptibility testing kits and reagents for use with government-owned VITEK 2 XL Automated Microbial Identification System, VITEK MS Automated Mass Spectrometry Microbial Identification System, BACT/ALERT VIRTUO Microbial Detection System; use of VITEK MS Prime Analyzer, including service agreements for the analyzers for the Department of Pathology at TAMC. The contract will be for a 12-month base period plus four 12-month options.

The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source, and no other suppliers or services will satisfy agency requirements. The NAICS code is 325413.

This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. All questions and responses concerning this notice shall be emailed to megumi.kuwada.civ@health.mil.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.